BioCentury
ARTICLE | Company News

Biocon, SBI Holdings deal

December 23, 2013 8:00 AM UTC

Biocon partnered with Quark Pharmaceuticals Inc. to co-develop therapeutics using Quark's short interfering RNA technology. Under the deal, Biocon gains rights to co-develop and commercialize Quark's...